Soru

Zorluk: ZorPsychopharmacology and Psychological Therapies

A young adult male is brought to the inpatient psychiatric unit by his family due to a profound decline in functioning over the past two weeks. The patient has been entirely mute, persistently holds his arms in rigid, unnatural postures for hours, and refuses all oral intake. His current daily medication regimen includes risperidone and fluoxetine. Vital signs show a heart rate of 105/min105/\text{min} and blood pressure of 130/85 mm Hg130/85\text{ mm Hg}; he is afebrile. The psychiatry team suspects catatonia. Arrange the following management steps in the most appropriate sequential order for evaluating and treating this patient's current condition.

  1. 1Discontinue risperidone therapy immediately
  2. 2Administer an intravenous lorazepam challenge test
  3. 3Initiate a scheduled regimen of high-dose lorazepam
  4. 4Consult for and proceed with electroconvulsive therapy (ECT)

Cevap

The correct sequential order for managing catatonia is to first discontinue the offending antipsychotic, then perform a lorazepam challenge test, followed by initiating scheduled lorazepam therapy, and finally reserving electroconvulsive therapy for refractory cases.
The standard of care for treating catatonia requires a stepwise approach to maximize safety and efficacy. The absolute first step is the cessation of dopamine-blocking agents (such as risperidone), as these can worsen the catatonic state and provoke neuroleptic malignant syndrome. Once the offending agent is removed, the diagnosis is confirmed and initially treated with a lorazepam challenge. If the patient responds, they are placed on scheduled lorazepam to maintain the therapeutic effect. Electroconvulsive therapy (ECT) is generally reserved as a last-line treatment for medication-refractory catatonia, unless the patient is actively deteriorating with malignant catatonia (fever, autonomic instability), in which case it is used earlier.

Adım Adım Çözüm

1
Identify the diagnosis of catatonia and stop offending agents.
Risperidone is discontinued.
Dopamine antagonists like risperidone can precipitate or worsen catatonia and cross over into neuroleptic malignant syndrome.
2
Perform a diagnostic challenge.
An intravenous lorazepam challenge is administered.
This confirms the diagnosis, as most patients with catatonia will show rapid, albeit temporary, improvement following a dose of intravenous benzodiazepines.
3
Establish a maintenance treatment plan.
Scheduled, high-dose lorazepam is initiated.
Once responsiveness to benzodiazepines is established, standing doses are required to prevent relapse of catatonic symptoms while treating the underlying psychiatric illness.
4
Determine the next step if pharmacological treatment fails.
Electroconvulsive therapy (ECT) is considered.
ECT is highly efficacious but invasive, so it is strictly reserved for patients who do not respond to scheduled benzodiazepines, or those who present with malignant catatonia (severe autonomic instability).

Anahtar Kavram

Stepwise management of catatonia
Bu soruyu puanla